|
|
Volumn 2012, Issue , 2012, Pages 645-651
|
|
B- and T-cell prolymphocytic leukemia: antibody approaches.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
CD19 ANTIGEN;
CD20 ANTIGEN;
MONOCLONAL ANTIBODY;
PROTEIN P53;
RITUXIMAB;
TP53 PROTEIN, HUMAN;
ADULT;
AGED;
ALLOTRANSPLANTATION;
BIOSYNTHESIS;
CASE REPORT;
FEMALE;
GENETICS;
HEMATOLOGY;
HUMAN;
IMMUNOLOGY;
IMMUNOPHENOTYPING;
IMMUNOTHERAPY;
MALE;
METHODOLOGY;
MIDDLE AGED;
PROGNOSIS;
PROLYMPHOCYTIC LEUKEMIA;
REMISSION;
REPRODUCIBILITY;
REVIEW;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIBODIES;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTIGENS, CD19;
ANTIGENS, CD20;
FEMALE;
HEMATOLOGY;
HUMANS;
IMMUNOPHENOTYPING;
IMMUNOTHERAPY;
LEUKEMIA, PROLYMPHOCYTIC, B-CELL;
LEUKEMIA, PROLYMPHOCYTIC, T-CELL;
MALE;
MIDDLE AGED;
PROGNOSIS;
REMISSION INDUCTION;
REPRODUCIBILITY OF RESULTS;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR PROTEIN P53;
MLCS;
MLOWN;
|
|
EID: 84879369188
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation.v2012.1.645.3798657 Document Type: Review |
|
Times cited : (13)
|
|
References (0)
|
